The mouse brain contains ~100 million neurons interconnected in a vast array of neural circuits.
Introduction
The brain contains a multitude of neural circuits that control diverse functions, but the specific neuronal components of most circuits and their respective roles are largely a mystery [1] [2] [3] . The application of single cell RNA sequencing techniques has allowed rapid advances in defining the transcriptomes of brain neurons [1] [2] [3] [4] [5] [6] . However, much less is known about which of the vast numbers of neurons with known transcriptomes are interconnected to control specific functions.
Here we devised a strategy, "Connect-seq", to obtain additional information about the neuronal components of specified neural circuits. The strategy couples the use of conditional neurotropic viruses that cross synapses with transcriptome analysis of connected upstream neurons infected with virus to obtain the molecular identities of neurons connected in a circuit.
To test the strategy, we focused on neural circuits that transmit signals to corticotropin releasing hormone neurons (CRHNs) in the paraventricular nucleus of the hypothalamus (PVN) 7 . In response to danger, CRHNs induce increases in blood stress hormones that act on multiple tissue systems to coordinate appropriate physiological responses. Surges in blood stress hormones occur in response to a variety of external and internal dangers or 'stressors', including predator odors, tissue injury, inflammation, and emotional and psychological stress 7, 8 .
Studies using classical neuroanatomical and neurophysiological approaches have provided a large body of information on PVN inputs that may affect CRHNs and the effects of classical neurotransmitters on CRHN activity and function 7, [9] [10] [11] [12] . However, the exact identities of upstream neurons that control CRHN functions and the mechanisms by which they do so have not been defined.
Viral tracing studies indicate that CRHNs receive direct synaptic input from neurons in 31 different brain areas 8 . These include 19 areas of the hypothalamus, a brain area that integrates information from the body and external environment and organizes fitting behavioral and physiological responses. Neurons two or more synapses upstream of CRHNs are seen in additional areas, including one small area of the olfactory cortex that has proved key to stress hormone responses to predator odors 8 . The viral tracing studies provide an anatomical map of neurons directly presynaptic to CRHNs, but the molecular identities of those neurons are unknown.
If one could identify genes whose expression defines subsets of neurons upstream of CRHNs in different brain areas, one would have molecular tools to explore which subsets mediate responses to different stressors and to manipulate those subsets to gain insight into how they function. Information regarding neurotransmitters and neuromodulators used by the upstream neurons to communicate with CRHNs would, in addition, provide information relevant not only to an understanding of neural circuit functions, but also potential insights into pharmacological interventions to modify the functions of specific circuit components.
To test the Connect-seq strategy, we infected Cre recombinase-expressing CRHNs with a Credependent Pseudorabies virus (PRV) that travels retrogradely across synapses. Using flow cytometry, we isolated single virus-infected neurons and then used single cell RNA sequencing (RNA-seq) to define the transcriptomes of individual upstream neurons. These experiments revealed an enormous diversity of neurotransmitter and neuromodulator signaling molecules in neurons directly upstream of CRHNs, including more than 40 different neuropeptides. Many individual neurons coexpressed multiple different signaling molecules. These included neurons coexpressing neuropeptides with neurotransmitters or biogenic amines, as well as neurons coexpressing different neuropeptides. The combinations of signaling molecules expressed by different cells were extremely diverse. Upstream neurons expressing specific signaling molecules mapped to selected brain areas, demonstrating that Connect-seq can provide molecular tools with which to dissect the functions of individual neuronal components of neural circuits.
RESULTS

Transcriptome analysis of neurons upstream of CRHNs
We first developed a Pseudorabies virus, PRVB180, which has Cre recombinase-dependent expression of thymidine kinase (TK) fused to green fluorescent protein (GFP) ( Fig. 1a ). After infecting neurons expressing Cre, this virus will travel retrogradely across synapses to infect upstream neurons. We injected PRVB180 into the PVN of CRH-IRES-Cre (CRH-Cre) mice ( Fig.   1b ), which express Cre in CRHNs 13 . On day 3 post infection (d3pi), immunostaining of brain sections for GFP showed GFP+ (PRV+) neurons in the same brain areas as seen previously for PRVB177, which expresses TK-HA instead of TK-GFP and travels to directly presynaptic neurons on d3pi 8 . We next conducted transcriptome analysis of neurons upstream of CRHNs. We infected CRHNs with PRVB180 and on d3pi isolated the hypothalamus and dissociated the tissue into a single cell suspension ( Fig. 1c ). Using flow cytometry, we isolated GFP+ (PRV-infected) cells, one per well, in 96 well plates 14 . We then conducted RNA-seq on each cell by Illumina sequencing cDNAs prepared from each cell 15, 16 . Gene expression in individual cells was determined by alignment to the mouse genome using standard methods 17, 18 . We proceeded to analyze 124 cells that expressed neuronal markers but not markers of other cell types, such as glial cells (see Methods).
Neurons upstream of CRHNs express diverse neurotransmitters and neuromodulators
To characterize the neurons upstream of CRHNs, we focused on signaling molecules that neurons use to convey information to their downstream partners 19 . These include classical 'fast neurotransmitters', which act via ligand-gated ion channels on downstream neurons to rapidly activate or inhibit those neurons, and numerous neuromodulators that bind to G protein-coupled receptors (GPCRs) on downstream neurons to modulate their excitability. We reasoned that the large number of different signaling molecules in the brain and their differential expression among neurons could serve to 1) optimize the discovery of molecular identifiers that would distinguish different upstream neurons and 2) provide potential insight into the molecular mechanisms used by upstream neurons to communicate with CRHNs.
We identified a large number and variety of neurotransmitters and neuromodulators expressed by PRV-infected neurons upstream of CRHNs (Fig. 2 ). These included glutamate and GABA, which act via ligand-gated ion channels and are the major excitatory and inhibitory neurotransmitters in the brain, respectively. We also identified two other fast neurotransmitters that signal through ligand-gated ion channels, acetylcholine and glycine ( Fig. 2a, 2b ). All of these neurotransmitters can also act as neuromodulators by binding to specific GPCRs on downstream neurons.
The neurotransmitters were expressed in 40.3% of upstream neurons analyzed ( Fig. 2a ), but the number of neurons expressing different neurotransmitters varied ( Fig. 3a ). Glutamate and GABA were expressed in 16.1% and 19.4% of the neurons, respectively, while the other neurotransmitters were expressed in far fewer neurons (0.8% for acetylcholine and 4.0% for glycine) ( Fig. 2a ). CRHNs have ligand-gated channels for both glutamate 20 and GABA 21, 22 . And receive direct synaptic input from both neurotransmitters 11,23,24 . Our results suggest that CRHNs can be activated by many glutamatergic presynaptic neurons, but that many other upstream neurons may suppress CRHN activity via GABA transmission. Previous studies indicate that upstream GABAergic neurons can provide tonic inhibition to CRHNs, the release of which can lead to CRHN activation by disinhibition 11,25 . In addition, some upstream GABAergic neurons might be involved in stimulus-induced suppression of CRHN responses, as previously reported for certain odors 26, 27 .
Small numbers of upstream neurons expressed biogenic amines (dopamine, norepinephrine, serotonin, or histamine) ( Fig. 2b, 3b ). These molecules, which signal through GPCRs, have widespread effects in the brain, can also act on peripheral tissues, and are the targets of numerous pharmacological agents 28 . Interestingly, several biogenic amines have reported effects on stress hormones 7, 11 and previous studies indicate that CRHNs have serotonin receptors and can be depolarized by serotonin 29 . By identifying the functions of different biogenic amine-expressing neurons upstream of CRHNs and determining how the amines affect CRHNs, it is possible that small molecule agonists or antagonists for specific biogenic amine receptors or their transporters could ultimately be employed to block or enhance the effects of particular stimuli on CRHNs.
Less common types of neurotransmitters/neuromodulators were also identified in small numbers of upstream neurons. These included the gaseous neuromodulators carbon monoxide and nitric oxide, as well as D-serine, the cannabinoid anandamide, and the purines ATP and adenosine ( Fig. 2b, 3c ).
Remarkably, 43 different neuropeptides were identified in neurons upstream of CRHNs ( Fig. 2b,   3d ). Neuropeptides can act as neuromodulators to enhance or dampen neuronal excitability by binding to GPCRs on downstream neurons 30,31 . Neuropeptide expression was seen in 69.4% of upstream neurons ( Fig. 2a ). The number of neurons expressing different neuropeptides ranged from a single neuron (e.g. gastrin releasing peptide and neuropeptide Y) to 20 neurons (arginine vasopressin) ( Fig. 2b, 3d ). The large number of neuropeptides identified in upstream neurons and their differential expression among the upstream neurons provides a rich set of tools for superimposing a molecular map on the anatomical map of CRHN upstream circuits and for dissecting the functions of different subsets of upstream neurons.
Upstream neurons can express multiple signaling molecules
Many of the upstream neurons expressed more than one neurotransmitter and/or neuromodulator ( Fig. 4a and Supplementary Fig.1 ). More than 85% of neurons expressed at least one of the signaling molecules examined (Fig. 4b) . Strikingly, 55% of the neurons expressed two or more signaling molecules and 21.8% expressed four or more ( Fig. 2b, 4b ).
Many upstream neurons coexpressed a given neuropeptide together with glutamate or GABA ( Fig. 2b, 4c ) and/or, in some cases, a biogenic amine ( Fig. 2b, 4d ) or other neuromodulator ( Fig.   2b, 4e ). This is consistent with previous reports that the neuropeptide POMC can be coexpressed with glutamate in some neurons, but GABA in others 32,33 . In our experiments, of five neurons expressing Cck (cholecystokinin), two coexpressed glutamate and one coexpressed GABA, and of twelve neurons expressing Tac1 (tachykinin1), one coexpressed glutamate and two coexpressed GABA. We also found Cck and Tac1 coexpressed with either glutamate or GABA in different neurons in another, large-scale study that analyzed single neurons from the hypothalamus 5 .
It is known that neurons expressing a neuropeptide or biogenic amine can also express a classical neurotransmitter 4, 5, 31, 34, 35 . These results further indicate that many neuropeptides can be coexpressed with glutamate in some upstream neurons but with GABA in others. Of 34 neuropeptides coexpressed with glutamate or GABA in our studies, twelve were coexpressed with glutamate in some neurons and GABA in others ( Fig. 4c ).
These results raise the possibility that individual neuropeptides could exert different modulatory effects on CRHNs depending on whether they are released onto CRHNs together with glutamate or GABA. For example, if a neuropeptide acts to enhance CRHN excitability, it may further enhance glutamate stimulation of CRHNs, but dampen GABAergic suppression of CRHNs. Our observations suggest the possibility of a complex patterning of stimulatory, inhibitory, and neuromodulatory effects that act at the level of synaptic input to CRHNs to fine tune the effects of upstream inputs on the CRHNs.
Upstream neurons can coexpress different combinations of neuropeptides
These studies also revealed many upstream neurons expressing different combinations of neuropeptides. As noted above, neuropeptides were expressed in 69% of the neurons upstream of CRHNs. While 38% of upstream neurons expressed a single neuropeptide, 32% coexpressed two or more, and a few neurons expressed 5-7 neuropeptides each ( Fig. 5a, 5b ).
These results are consistent with previous reports that neurons expressing a given neuropeptide can also express another neuropeptide 36,37 , but the number of neuropeptides that could be coexpressed in single neurons was unexpected.
To further investigate the coexpression of neuropeptides in single neurons, we compared the levels of expression of different neuropeptides in individual neurons. At the level of single neurons, a few neurons expressed two or three neuropeptides at similar levels ( Fig. 5c ).
However, many other neurons expressed one neuropeptide at a much higher level than one or more others expressed in the same cell. These results suggest that while a neuron might express multiple neuropeptides, the downstream effects of one might predominate over the effects of others. Some neuropeptides, as well as other signaling molecules, were expressed at very different levels in different cells ( Fig. 6a, 6b ), raising the possibility that they might play a more important role in signaling to CRHNs by some upstream neurons than others.
Surprisingly, in addition to being expressed at different levels among neurons, neuropeptides were expressed in different combinations in different neurons ( Fig. 7) . For example, of seven neurons expressing Gal (galanin), Avp (arginine vasopressin) was coexpressed in five, Cartpt (cocaine-and amphetamine-regulated transcript protein) in three, and seven other neuropeptides each in 1-2 of the Gal+ neurons ( Fig. 7a ). In large-scale single cell RNA-seq data from the hypothalamus, we found that, altogether, 100 Gal-expressing neurons coexpressed nineteen other neuropeptides, including Avp and Cartpt 5 .
Using a higher transcript threshold to define gene expression in our experiments (>250 FPKM (fragments per kilobase of transcript per million mapped reads) instead of >10 FPKM), the number of combinations of neuropeptides in different neurons was reduced, suggesting that much of the variability seen using the 10 FPKM threshold was the result of low level expression of neuropeptides ( Fig. 7b ). These results suggest that there may be more diversity in neuropeptide expression in single neurons than previously appreciated but that much of that diversity may result from the expression of neuropeptides at a low level.
Upstream neurons expressing specific neuromodulators map to selected brain areas
One goal of these studies was to uncover molecular identifiers of upstream neurons that would allow for a molecular map to be superimposed on the anatomical map of neurons upstream of CRHNs. To investigate this possibility, we examined neurons upstream of CRHNs for the expression of several neuromodulators we had identified by transcriptome analysis of upstream neurons.
Using the Allen Brain Atlas (http://mouse.brain-map.org/) 38 , we examined the expression of a number of neuropeptides we had identified in different areas of the hypothalamus previously shown to contain neurons directly upstream of CRHNs 8 . Consistent with the fact that we had identified the neuropeptides in upstream neurons we isolated from the hypothalamus, all of the neuropeptides for which there was adequate information in the atlas were expressed in at least one of those hypothalamic areas in the atlas (Fig. 8a) .
To analyze the locations of upstream neurons expressing specific neuromodulators, we first infected Cre-expressing CRHNs with PRVB177, which has Cre-dependent expression of hemagglutinin (HA)-tagged TK 8 . After 3 days, when the virus had crossed one synapse to infect immediately upstream neurons, we costained brain sections with riboprobes for specific neuromodulators and anti-HA antibodies to detect PRV-infected neurons ( Fig. 8b and Supplementary Fig. 2 ).
Avp was detected in PRV+ neurons in five brain areas, including four areas of the hypothalamus ( Fig. 8b) . In contrast, Tac1 (tachykinin 1) and Npy (neuropeptide Y) were each seen in PRV+ neurons in only one hypothalamic area, the DMH for Tac1 and the ARC for Npy. Hdc (histidine decarboxylase), a marker for the expression of the biogenic amine, Histamine, was seen in six hypothalamic areas and one other brain area.
The selected expression of neuromodulators we identified in upstream neurons in only certain brain areas confirms that data obtained using Connect-seq can be used to superimpose a molecular map on the anatomical map of neural circuits upstream of CRHNs (Fig. 9 ). This information can be used to map functional responses to particular stressors to subsets of upstream neurons in specific brain areas, thereby providing insight into the functional meaning of the anatomical/molecular mapping and suggesting tools to dissect the roles of specific neuronal subsets in particular functions.
Discussion
The brain contains a vast number of neural circuits that govern diverse functions, but the neuronal components of those circuits and their individual contributions to circuit function are largely undefined [1] [2] [3] 19 . In the present studies, we devised a strategy, termed 'Connect-seq', which utilizes a combination of viral tracing and single cell transcriptomics to uncover the molecular identities of neurons upstream of a specific set of neurons and reveal the neurotransmitters and neuromodulators they use to communicate with their downstream synaptic targets.
We used Connect-seq to gain insight into circuits that transmit information to CRH neurons that 
Methods
Mice. CRH-IRES-Cre (CRH-Cre) mice were generated as described previously 13 . All procedures involving mice were approved by the Fred Hutchinson Cancer Research Center Institutional Animal Care and Use Committee. C57BL/6J mice were purchased from The Jackson Laboratory.
Pseudorabies Viral Vectors
Construction of PRVB177 was described previously 8 . PRVB180 construct was made according to the methods described previously 8 
Stereotaxic injections
Viruses were injected into the PVN of CRH-Cre mice as described previously 8 . All injections were done under inhalation anesthesia of 2% isoflurane. Briefly, 1ul of PRVs (PRVB180 & PRVB177; 1-1.5 × 10 6 p.f.u.) were loaded into a 1ul syringe and were injected into the brain at a rate of 100nl per minute using a Stereotaxic Alignment System (David Kopf Instruments). The needle was inserted to the PVN based on a stereotaxic atlas 43 . After recovery, animals were singly housed with regular 12 h dark/light cycles, and food and water were provided ad libitum.
Isolation of PRV-infected single cells using flow cytometry
Adult CRH-Cre mice aged 2-4 month were injected with PRVB180. After three days, mice were euthanized by cervical dislocation, the brain quickly removed and submerged into ice-cold Biochemical Corporation)). Dissociated hypothalamic tissue were transferred into 5 ml of dissociation buffer and incubated for 30 min at room temperature. After incubation, tissue pieces were gently triturated 2-3 times through a series of fire-polished glass Pasteur pipettes with decreasing diameters of ~600 µm, ~300 µm, and ~150 µm to dissociate tissue into a cloudy suspension. Cells were sieved using a 70 µm cell strainer into 50 ml tubes containing 10 ml of ice-cold Hibernate-A medium with 1% BSA. Cells were then centrifuged at 800 rpm for 5 min at 4 ºC, washed once with ice-cold Hibernate-A medium and cell pellet obtained was resuspended in ~500 µl of Hibernate-A medium containing 2% B27 (ThermoFisher) and DAPI (0.5 ng ml -1 ) to stain for dead cells. Cells were then sieved using a 40 µM cell strainer to obtain single cell suspension and proceeded to FACS (fluorescence-activated cell sorting).
PRV-infected single cells were isolated based on the fluorescence emitted by TK-GFP using flow cytometry (FACSAria II; BD Biosciences) according to methods described previously 14 with minor modifications. Briefly, cells were first sorted based on their size to isolate single cells using Forward (FSC) and Side Scatter (SSC) gates, and then high GFP and low DAPI (to obtain live cells) cells were individually placed in 96 well plates containing 3 µl of RLT Plus lysis buffer (#1053393; Qiagen).
Single-cell RNA Sequencing
Single cells were then processed immediately to generate cDNA libraries using SMART- the "cuffnorm" utility, using the "classic-fpkm" normalization method, for use in downstream analysis. A total of 384 PRV-infected cells were sequenced at a depth of at least 7,000,000 reads (median ~ 6,700,000, range ~17,500 to ~13,300,000). 347 cells that expressed at least 500 genes per cell were considered for downstream analysis. On average, cells expressed ~2,600 genes per cell (median ~2,500, range ~520 to 10,300).
Analysis of marker genes
Transcriptome data were manually inspected for transcripts of cell type markers to include neurons and exclude non-neuronal cells. We used a threshold of ≥10 FPKM for cell type markers as in our previous analysis of olfactory sensory neurons 44 . Cells were classified using a criterion that a cell must express two or more of six different marker genes of a cell type but not more than two of other cell types. We used the following genes to classify cells: Snap25, Map2, Syp, Kif5c, Dlg2, and Dlg4 for neurons; Aldh1l1, Aldoc, Aqp4, Gfap, S100b, and Sparcl1 for astrocytes; Adgre1, Aif1, Tmem119, Cxcr1, Hexb, and Mafb for microglia; Cldn11, Mbp, Mobp, Mog, Pdgfra, and Gpr17 for oligodendrocytes. If a cell remained unclassified but expressed one marker of neurons but not other cell types, we additionally examined markers for the excitatory neurotransmitter glutamate (Slc17a/6/7/8) and the inhibitory neurotransmitter GABA (Gad1/2) and included cells with one or more of those markers. For neurotransmitters and neuromodulators, we used marker genes that encode rate-limiting enzymes required for their biosynthesis or vesicular transporters that package synaptic vesicles with specific neurotransmitters. For neuropeptides, we used genes encoding known ligands of GPCRs obtained from the International Union of Basic and Clinical Pharmacology (IUPHAR)/ British Pharmacological Society (BPS) website (http://www.guidetopharmacology.org) and those with evidence for having an electrophysiological effect on neurons.
In situ hybridization
Dual labeling studies to examine the expression of markers in PRV-infected cells were performed essentially as described previously 8, 44 . Coding region fragments of Avp, Tac1, Npy, and Hdc were PCR-amplified from mouse brain cDNA or genomic DNA and cloned into the pCR4 Topo vector (Thermo Fisher). Digoxigenin (DIG)-labeled riboprobes were prepared using the DIG RNA Labeling Mix (Roche). The PVN of CRH-Cre mice aged 2-4 months was injected with PRVB177, as described above. After three days, mice were euthanized by cervical dislocation, and brains were frozen in OCT (Sakura) on dry ice and stored at -80 ºC. Coronal cryostat sections of 20µm were hybridized to DIG-labeled riboprobes at 56 ºC for 13-16 h.
Costaining for HA (PRVB177) and neuropeptides riboprobes. After hybridization with riboprobes, sections were washed twice for 5 min at 63 ºC in 5x SSC followed by twice for 30 min at 63 o C in 0.2x SSC. Sections were then incubated with horseradish peroxidase (POD)-conjugated 
Cell counting
Sections were analyzed essentially as described previously 8 . Briefly, images were collected using an AxioCam camera and AxioImager.Z2 microscope with an apotome device (Zeiss). A mouse brain atlas was used to identify brain structures microscopically and in digital photos.
Every fifth section was analyzed for all experiments.
Abbreviations for brain areas. Abbreviations used for brain areas are according to a mouse brain atlas 43 and our previous report 8 (c) Following PRVB180 replication in CRHNs and travel of virus to upstream neurons, the hypothalamus was isolated and dissociated to obtain single cells. Flow cytometry was used to deposit cells with high GFP (FITC-A) and low DAPI-A staining, one per well, in multiwell plates. RNA-seq was used to determine their molecular identities and the signaling molecules (neurotransmitters/neuromodulators) they expressed. The locations of upstream neurons expressing selected signaling molecules were then determined, allowing a molecular map of upstream neurons to be superimposed on the existing anatomical circuit map. (c-e) Graphs show the number of cells that coexpressed different neuropeptides with the excitatory neurotransmitter, glutamate or the inhibitory neurotransmitter, GABA (c) or with different neuromodulatory biogenic amines (d) or other neuromodulators (e). 
Supplementary Figure 1. Coexpression of different signaling molecules in upstream neurons.
Graphs show the number of upstream neurons that coexpressed different neurotransmitters with different biogenic amines (a) or that coexpressed other neuromodulators with GABA or glutamate (b).
